This symposium is presented by AIM at Melanoma and the University of California Melanoma & Skin Cancer Consortium held at the Moores Cancer Center at UC San Diego Health.

The UC Melanoma and Skin Cancer Consortium (UCMSCC) applies state-of-the-art research and clinical expertise from all five of UC’s NCI-designated Comprehensive Cancer Centers to disparity in access to clinical trials, and to discovery and development of new treatment options.

Moores Cancer Center at UC San Diego Health

Established in 1978, Moores Cancer Center is one of just 53 National Cancer Institute-Designated Comprehensive Cancer Centers in the United States, and the only one in the San Diego region. Such centers are prominent among the leading institutions in the nation dedicated to scientific innovation and clinical excellence. This designation — reserved for centers with the highest achievements in cancer research, clinical care, education and community contributions — makes an enormous difference to their patients. Studies show that outcomes are better at NCI-designated centers. Their cancer services were ranked #1 in San Diego, with 10 specialties ranking nationally by U.S. News & World Report in its 2022-2023 “Best Hospitals” survey.

Date: Saturday – February 17, 2024
Time: 12:00 PM (ET)| 11:00 AM (CT) | 10:00 AM (MT) | 9:00 AM (PT)
Format: Presented both virtually and in-person; Registration required for both formats, please register below

Symposium Location:
Moores Cancer Center, University of California, San Diego, Goldberg Auditorium 2nd Floor, 3855 Health Sciences Dr, San Diego, CA

Athena Parking Structure
• Drive southeast on Genesee Ave
• Turn right onto Regents Road
• Turn right onto Health Sciences Dr
• Parking structure will be on the right and across the street from the Moores Cancer Center
• Turn right to enter the structure.

Presenters & Topics

8:30 AM PT

Registration For In-Person Attendees

9:00 AM PT

Welcome & Opening Remarks
Gregory A Daniels, MD, PhD 
Medical Oncologist
Professor of Medicine
UC San Diego Health Moores Cancer Center

9:10 AM PT

The Making of Melanoma
Kenneth Linden, PhD, MD 
Department of Dermatology
Chow Family Comprehensive Cancer Center
Co-Director, University of California Irvine Melanoma Center
Co-Director, Skin Disease Oriented Team; UC Irvine
Chair, Institutional Review Board; UC Irvine

9:30 AM PT

Through The Lens Of An Ocular Oncologist
Nathan L. Scott, MD, MPP 
Assistant Professor
Clinical Ophthalmologist – Vitreoretinal Disease and Surgery
Division Chief, Ocular Oncology
Associate Member, Solid Tumor UC San Diego Health Moores Cancer Center
Viterbi Family Dept of Ophthalmology Shiley Eye Institute; UC San Diego

9:50 AM PT

Preventing Melanoma Recurrence After Surgery
Bartosz Chmielowski, MD, PhD
Health Sciences Clinical Professor
Division of Hematology- Medical Oncology
Jonsson Comprehensive Cancer Center
UC Los Angeles

10:10 AM PT


10:35 AM PT


10:45 AM PT

Future Directions In Immunotherapy
Adil Daud, MD
Professor of Clinical Medicine and Dermatology
Director, Melanoma Clinical Research
UC San Francisco Helen Diller Family Comprehensive Cancer Center

11:05 AM PT

Round Table

Soo Park, MD
Medical Oncologist
Associate Professor of Medicine
UC San Diego Health Moores Cancer Center

Round Table Participants:

Bortosz Chmielowski, MD, PhD

Gregory A Daniels, MD, PhD

Adil Daud, MD

Kenneth Linden, MD PhD

Nathan L. Scott, MD, MPP

11:25 AM PT

Patient Resources
Ann Garst Taylor
Director Community Engagement
AIM at Melanoma Foundation

11:30 AM PT


Registration Form